Skip to main content
SpringerLink
Log in

Functional Neuroradiology of Multiple Sclerosis: Non-BOLD Techniques

  • Chapter
  • First Online:
Functional Neuroradiology

  • 1466 Accesses

Abstract

Recent technical improvements in the field of magnetic resonance imaging (MRI), including the advent and more widespread use of high-field strengths, have allowed for the introduction of nonconventional MR sequences on a routine basis. These have provided interesting insight into the pathophysiology of multiple sclerosis (MS) and tissue integrity and have tried to analyze functional aspects of brain activity and structure such as, among others, perfusion, water distribution, and metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

DWI

  1. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, et al. Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging. 2001;13(4):534–46.

    PubMed  Google Scholar 

  2. Basser PJ, Mattiello J, LeBihan D. Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B. 1994;103(3):247–54.

    CAS  PubMed  Google Scholar 

  3. Wheeler-Kingshott CA, Ciccarelli O, Schneider T, Alexander DC, Cercignani M. A new approach to structural integrity assessment based on axial and radial diffusivities. Funct Neurol. 2012;27(2):85–90.

    PubMed  PubMed Central  Google Scholar 

  4. Jelescu IO, Veraart J, Adisetiyo V, Milla SS, Novikov DS, Fieremans E. One diffusion acquisition and different white matter models: how does microstructure change in human early development based on WMTI and NODDI? Neuroimage. 2015;107:242–56.

    PubMed  Google Scholar 

  5. Zhang H, Schneider T, Wheeler-Kingshott CA. Alexander DC.NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage. 2012;61(4):1000–16.

    PubMed  Google Scholar 

  6. Sherbondy AJ, Rowe MC, Alexander DC. MicroTrack: an algorithm for concurrent projectome and microstructure estimation. Med Image Comput Comput Assist Interv. 2010;13(Pt 1):183–90.

    PubMed  Google Scholar 

  7. Palesi F, Tournier JD, Calamante F, Muhlert N, Castellazzi G, Chard D, et al. Contralateral cerebello-thalamo-cortical pathways with prominent involvement of associative areas in humans in vivo. Brain Struct Funct. 2015;220(6):3369–84.

    PubMed  Google Scholar 

  8. Li HQ, Yin B, Quan C, Geng DY, Yu H, Bao YF, et al. Evaluation of patients with relapsing-remitting multiple sclerosis using tract-based spatial statistics analysis: diffusion kurtosis imaging. BMC Neurol. 2018;18(1):108.

    PubMed  PubMed Central  Google Scholar 

  9. Moccia M, de Stefano N, Barkhof F. Imaging outcome measures for progressive multiple sclerosis trials. Mult Scler. 2017;23(12):1614–26.

    PubMed  PubMed Central  Google Scholar 

  10. Schmierer K, Wheeler-Kingshott CA, Boulby PA, Scaravilli F, Altmann DR, Barker GJ, et al. Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage. 2007;35(2):467–77.

    PubMed  Google Scholar 

  11. Seewann A, Vrenken H, van der Valk P, Blezer EL, Knol DL, Castelijns JA, et al. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Arch Neurol. 2009;66(5):601–9.

    PubMed  Google Scholar 

  12. Bodini B, Cercignani M, Khaleeli Z, Miller DH, Ron M, Penny S, et al. Corpus callosum damage predicts disability progression and cognitive dysfunction in primary-progressive MS after five years. Hum Brain Mapp. 2013;34(5):1163–72.

    PubMed  Google Scholar 

  13. Dineen RA, Vilisaar J, Hlinka J, Bradshaw CM, Morgan PS, Constantinescu CS, et al. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain. 2009;132(Pt 1):239–49.

    CAS  PubMed  Google Scholar 

  14. Schoonheim MM, Hulst HE, Brandt RB, Strik M, Wink AM, Uitdehaag BM, et al. Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis. Neurology. 2015;84(8):776–83.

    PubMed  Google Scholar 

  15. Liu Y, Duan Y, Huang J, Ren Z, Ye J, Dong H, et al. Multimodal quantitative MR imaging of the thalamus in multiple sclerosis and neuromyelitis optica. Radiology. 2015;277(3):784–92.

    PubMed  Google Scholar 

  16. Hulst HE, Steenwijk MD, Versteeg A, Pouwels PJ, Vrenken H, Uitdehaag BM, et al. Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions. Neurology. 2013;80(11):1025–32.

    CAS  PubMed  Google Scholar 

  17. Welton T, Kent D, Constantinescu CS, Auer DP, Dineen RA. Functionally relevant white matter degradation in multiple sclerosis: a tract-based spatial meta-analysis. Radiology. 2015;275(1):89–96.

    PubMed  Google Scholar 

  18. Mesaros S, Rocca MA, Kacar K, Kostic J, Copetti M, Stosic-Opincal T, et al. Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis. Neurology. 2012;78(13):969–75.

    CAS  PubMed  Google Scholar 

  19. Bodini B, Khaleeli Z, Cercignani M, Miller DH, Thompson AJ, Ciccarelli O. Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM. Hum Brain Mapp. 2009;30(9):2852–61. https://doi.org/10.1002/hbm.20713.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Steenwijk MD, Daams M, Pouwels PJ, Balk LJ, Tewarie PK, Geurts JJ, et al. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis. Hum Brain Mapp. 2015;36(5):1796–807.

    PubMed  PubMed Central  Google Scholar 

  21. Sbardella E, Petsas N, Tona F, Prosperini L, Raz E, Pace G, et al. Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients. PLoS One. 2013;8(5):e63250.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Martin AR, et al. Translating state-of-the-art spinal cord MRI techniques to clinical use: a systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI. Neuroimage Clin. 2015;10:192–238.

    PubMed  PubMed Central  Google Scholar 

MRS

  1. Rovira A, Alonso J. 1H magnetic resonance spectroscopy in multiple sclerosis and related disorders. Neuroimaging Clin N Am. 2013;23(3):459–74.

    PubMed  Google Scholar 

  2. Sajja BR, Wolinsky JS, Narayana PA. Proton magnetic resonance spectroscopy in multiple sclerosis. Neuroimaging Clin N Am. 2009;19(1):45–58.

    PubMed  PubMed Central  Google Scholar 

  3. De Stefano N, Filippi M. MR spectroscopy in multiple sclerosis. J Neuroimaging. 2007;17(Suppl 1):31S–5S.

    PubMed  Google Scholar 

PWI

  1. Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, Inglese M. White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis. J Neurol Sci. 2009;282(1–2):28–33.

    PubMed  PubMed Central  Google Scholar 

  2. D’haeseleer M, Hostenbach S, Peeters I, Sankari SE, Nagels G, De Keyser J, et al. Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis? J Cereb Blood Flow Metab. 2015;35(9):1406–10.

    PubMed  PubMed Central  Google Scholar 

  3. Lapointe E, Li DKB, Traboulsee AL, Rauscher A. What have we learned from perfusion MRI in multiple sclerosis? AJNR Am J Neuroradiol. 2018;39(6):994–1000.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Monti L, Morbidelli L, Rossi A. Impaired cerebral perfusion in multiple sclerosis: relevance of endothelial factors. Biomark Insights. 2018;13:1177271918774800.

    PubMed  PubMed Central  Google Scholar 

  5. D’Ortenzio RM, Hojjat SP, Vitorino R, Cantrell CG, Lee L, Feinstein A, et al. Comparison of quantitative cerebral blood flow measurements performed by bookend dynamic susceptibility contrast and arterial spin-labeling MRI in relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol. 2016;37(12):2265–72.

    PubMed  PubMed Central  Google Scholar 

  6. Essig M, Shiroishi MS, Nguyen TB, Saake M, Provenzale JM, Enterline D, et al. Perfusion MRI: the five most frequently asked technical questions. AJR Am J Roentgenol. 2013;200(1):24–34.

    PubMed  PubMed Central  Google Scholar 

  7. Marshall O, Lu H, Brisset J-C, Xu F, Liu P, Herbert J, et al. Impaired cerebrovascular reactivity in multiple sclerosis. JAMA Neurol. 2014;71(10):1275–81.

    PubMed  PubMed Central  Google Scholar 

  8. Koudriavtseva T, Plantone D, Renna R, Inglese M. Brain perfusion by arterial spin labeling MRI in multiple sclerosis. J Neurol. 2015;262(7):1769–71.

    PubMed  Google Scholar 

  9. Lassmann H. The pathologic substrate of magnetic resonance alterations in multiple sclerosis. Neuroimaging Clin N Am. 2008;18(4):563–76, ix.

    PubMed  Google Scholar 

  10. Saindane AM, Law M, Ge Y, Johnson G, Babb JS, Grossman RI. Correlation of diffusion tensor and dynamic perfusion MR imaging metrics in normal-appearing corpus callosum: support for primary hypoperfusion in multiple sclerosis. AJNR Am J Neuroradiol. 2007;28(4):767–72.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Debernard L, Melzer TR, Van Stockum S, Graham C, Wheeler-Kingshott CA, Dalrymple-Alford JC, et al. Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry. 2014;85(5):544–51.

    PubMed  Google Scholar 

  12. Ota M, Sato N, Nakata Y, Ito K, Kamiya K, Maikusa N, et al. Abnormalities of cerebral blood flow in multiple sclerosis: a pseudocontinuous arterial spin labeling MRI study. Magn Reson Imaging. 2013;31(6):990–5.

    PubMed  Google Scholar 

  13. Zhang X, Guo X, Zhang N, Cai H, Sun J, Wang Q, et al. Cerebral blood flow changes in multiple sclerosis and neuromyelitis optica and their correlations with clinical disability. Front Neurol. 2018;9:305.

    PubMed  PubMed Central  Google Scholar 

  14. Marshall O, Chawla S, Lu H, Pape L, Ge Y. Cerebral blood flow modulation insufficiency in brain networks in multiple sclerosis: a hypercapnia MRI study. J Cereb Blood Flow Metab. 2016;36(12):2087–95.

    PubMed  PubMed Central  Google Scholar 

SWI

  1. Schenck JF. The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med Phys. 1996;23(6):815–50. Review.

    CAS  PubMed  Google Scholar 

  2. Liu C, Li W, Tong KA, Yeom KW, Kuzminski S. Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain. J Magn Reson Imaging. 2015;42(1):23–41. https://doi.org/10.1002/jmri.24768.

    Article  PubMed  Google Scholar 

  3. Wisnieff C, Ramanan S, Olesik J, Gauthier S, Wang Y, Pitt D. Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron. Magn Reson Med. 2015;74(2):564–70.

    CAS  PubMed  Google Scholar 

  4. Cortese R, Magnollay L, Tur C, Abdel-Aziz K, Jacob A, De Angelis F, et al. Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD. Neurology. 2018;90(14):e1183–90.

    PubMed  Google Scholar 

  5. Mistry N, Abdel-Fahim R, Samaraweera A, Mougin O, Tallantyre E, Tench C, et al. Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions. Mult Scler J. 2016;22:1289–96.

    Google Scholar 

  6. Tallantyre EC, Dixon JE, Donaldson I, Owens T, Morgan PS, Morris PG, et al. Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology. 2011;76(6):534–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Wuerfel J, Sinnecker T, Ringelstein EB, Jarius S, Schwindt W, Niendorf T, et al. Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis. Mult Scler. 2012;18(11):1592–9.

    PubMed  Google Scholar 

  8. Hagemeier J, Heininen-Brown M, Gabelic T, Guttuso T Jr, Silvestri N, Lichter D, et al. Phase white matter signal abnormalities in patients with clinically isolated syndrome and other neurologic disorders. AJNR Am J Neuroradiol. 2014;35(10):1916–23.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Chen W, Gauthier SA, Gupta A, Comunale J, Liu T, Wang S, et al. Quantitative susceptibility mapping of multiple sclerosis lesions at various ages. Radiology. 2014;271(1):183–92.

    PubMed  Google Scholar 

  10. Mehta V, Pei W, Yang G, Li S, Swamy E, Boster A, et al. Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS One. 2013;8(3):e57573.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Chawla S, Kister I, Sinnecker T, Wuerfel J, Brisset JC, Paul F, et al. Longitudinal study of multiple sclerosis lesions using ultra-high field (7T) multiparametric MR imaging. PLoS One. 2018;13(9):e0202918.

    PubMed  PubMed Central  Google Scholar 

  12. Ropele S, Enzinger C, Fazekas F. Iron mapping in multiple sclerosis. Neuroimaging Clin N Am. 2017;27(2):335–42.

    PubMed  Google Scholar 

  13. Ropele S, Kilsdonk ID, Wattjes MP, Langkammer C, de Graaf WL, Frederiksen JL, et al. Determinants of iron accumulation in deep grey matter of multiple sclerosis patients. Mult Scler. 2014;20(13):1692–8.

    CAS  PubMed  Google Scholar 

  14. Khalil M, Langkammer C, Pichler A, Pinter D, Gattringer T, Bachmaier G, et al. Dynamics of brain iron levels in multiple sclerosis: a longitudinal 3T MRI study. Neurology. 2015;84(24):2396–402.

    CAS  PubMed  Google Scholar 

MTR

  1. Bagnato F, Hametner S, Franco G, Pawate S, Sriram S, Lassmann H, et al. Selective inversion recovery quantitative magnetization transfer brain MRI at 7T: clinical and postmortem validation in multiple sclerosis. J Neuroimaging. 2018;28(4):380–8.

    PubMed  PubMed Central  Google Scholar 

  2. Zheng Y, Lee JC, Rudick R, Fisher E. Long-term magnetization transfer ratio evolution in multiple sclerosis white matter lesions. J Neuroimaging. 2018;28(2):191–8.

    PubMed  Google Scholar 

  3. Mottershead JP, Schmierer K, Clemence M, Thornton JS, Scaravilli F, Barker GJ, et al. High field MRI correlates of myelin content and axonal density in multiple sclerosis—a post-mortem study of the spinal cord. J Neurol. 2003;250(11):1293–301.

    CAS  PubMed  Google Scholar 

  4. Van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol. 1999;46(5):747–54.

    PubMed  Google Scholar 

  5. Vavasour IM, Laule C, Li DK, Traboulsee AL, MacKay AL. Is the magnetization transfer ratio a marker for myelin in multiple sclerosis? J Magn Reson Imaging. 2011;33(3):713–8.

    PubMed  Google Scholar 

  6. Berry I, Barker GJ, Barkhof F. A multicenter measurement of magnetization transfer ratio in normal white matter. J Magn Reson Imaging. 1999;9(3):441–6.

    CAS  PubMed  Google Scholar 

  7. Henkelman RM, Huang X, Xiang QS, Stanisz GJ, Swanson SD, Bronskill MJ. Quantitative interpretation of magnetization transfer. Magn Reson Med. 1993;29(6):759–66.

    CAS  PubMed  Google Scholar 

  8. Yarnykh VL. Fast macromolecular proton fraction mapping from a single off-resonance magnetization transfer measurement. Magn Reson Med. 2012;68(1):166–78.

    CAS  PubMed  Google Scholar 

  9. Wu Y, Du H, Storey P, Glielmi C, Malone F, Sidharthan S, et al. Comprehensive brain analysis with automated high-resolution magnetization transfer measurements. J Magn Reson Imaging. 2012;35(2):309–17.

    PubMed  Google Scholar 

  10. Girard OM, Prevost VH, Varma G. Magnetization transfer from inhomogeneously broadened lines (ihMT): experimental optimization of saturation parameters for human brain imaging at 1.5 Tesla. Magn Reson Med. 2015;73(6):2111–21.

    PubMed  Google Scholar 

  11. Filippi M, Rocca MA. Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve. Neurotherapeutics. 2007;4(3):401–13.

    PubMed  PubMed Central  Google Scholar 

  12. Hayton T, Furby J, Smith KJ, Altmann DR, Brenner R, Chataway J, et al. Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis. J Neurol. 2009;256(3):427–35.

    CAS  PubMed  Google Scholar 

  13. Rovaris M, Judica E, Sastre-Garriga J, Rovira A, Sormani MP, Benedetti B, et al. Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis. Mult Scler. 2008;14(4):455–64.

    PubMed  Google Scholar 

  14. Amato MP, Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, et al. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology. 2008;71(9):632–8.

    CAS  PubMed  Google Scholar 

  15. Tur C, Penny S, Khaleeli Z, Altmann DR, Cipolotti L, Ron M, et al. Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis. Mult Scler. 2011;17(11):1324–32.

    CAS  PubMed  Google Scholar 

  16. Khaleeli Z, Altmann DR, Cercignani M. Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis. Arch Neurol. 2008;65(11):1454–9.

    PubMed  Google Scholar 

  17. Penny S, Khaleeli Z, Cipolotti L, Thompson A, Ron M. Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis. Neurology. 2010;74(7):545–52.

    CAS  PubMed  Google Scholar 

  18. Filippi M, Preziosa P, Copetti M, Riccitelli G, Horsfield MA, Martinelli V, et al. Gray matter damage predicts the accumulation of disability 13 years later in MS. Neurology. 2013;81(20):1759–6.

    PubMed  Google Scholar 

  19. Chen JT, Easley K, Schneider C, Nakamura K, Kidd GJ, Chang A, et al. Clinically feasible MTR is sensitive to cortical demyelination in MS. Neurology. 2013;80(3):246–52.

    PubMed  PubMed Central  Google Scholar 

  20. Samson RS, Cardoso MJ, Muhlert N, Sethi V, Wheeler-Kingshott CA, Ron M, et al. Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups. Mult Scler. 2014;20(10):1322–30.

    PubMed  Google Scholar 

  21. Ropele S, Fazekas F. Magnetization transfer MR imaging in multiple sclerosis. Neuroimaging Clin N Am. 2009;19(1):27–36.

    PubMed  Google Scholar 

  22. Filippi M, Rocca MA, De Stefano N, Enzinger C, Fisher E, Horsfield MA, et al. Magnetic resonance techniques in multiple sclerosis: the present and the future. Arch Neurol. 2011;68(12):1514–20.

    PubMed  Google Scholar 

  23. Fazekas F, Ropele S, Enzinger C, Seifert T, Strasser-Fuchs S. Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis. Mult Scler. 2002;8(6):479–84.

    CAS  PubMed  Google Scholar 

  24. Rocca MA, Mastronardo G, Rodegher M, Comi G, Filippi M. Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis. AJNR Am J Neuroradiol. 1999;20(5):821–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Agosta F, Rovaris M, Pagani E, Sormani MP, Comi G, Filippi M. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain. 2006;129(Pt 10):2620–7.

    PubMed  Google Scholar 

New Markers of Neuroinflammation

  1. Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med. 2011;365(23):2188–97.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Choi SR, Howell OW, Carassiti D, Magliozzi R, Gveric D, Muraro PA, et al. Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain. 2012;135(Pt 10):2925–37.

    PubMed  Google Scholar 

  3. Mathews VP, Caldemeyer KS, Lowe MJ, Greenspan SL, Weber DM, Ulmer JL. Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging. Radiology. 1999;211(1):257–63.

    CAS  PubMed  Google Scholar 

  4. Hagens M, van Berckel B, Barkhof F. Novel MRI and PET markers of neuroinflammation in multiple sclerosis. Curr Opin Neurol. 2016;29(3):229–36.

    CAS  PubMed  Google Scholar 

  5. Zurawski J, Lassmann H, Bakshi R. Use of magnetic resonance imaging to visualize leptomeningeal inflammation in patients with multiple sclerosis: a review. JAMA Neurol. 2017;74(1):100–9.

    PubMed  Google Scholar 

  6. Dousset V, Ballarino L, Delalande C, Coussemacq M, Canioni P, Petry KG, et al. Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis. AJNR Am J Neuroradiol. 1999;20(2):223–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Corot C, Robert P, Idée JM, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev. 2006;58(14):1471–504.

    CAS  PubMed  Google Scholar 

  8. Vellinga MM, Oude Engberink RD, Seewann A, Pouwels PJ, Wattjes MP, van der Pol SM, et al. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain. 2008;131(Pt 3):800–7.

    PubMed  Google Scholar 

  9. Vellinga MM, Vrenken H, Hulst HE, Polman CH, Uitdehaag BM, Pouwels PJ, et al. Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI to demonstrate diffuse inflammation in the normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients: an exploratory study. J Magn Reson Imaging. 2009;29(4):774–9.

    PubMed  Google Scholar 

  10. Dousset V, Brochet B, Deloire MS, Lagoarde L, Barroso B, Caille JM, et al. MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. AJNR Am J Neuroradiol. 2006;27(5):1000–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Gkagkanasiou M, Ploussi A, Gazouli M, Efstathopoulos EP. USPIO-enhanced MRI neuroimaging: a review. J Neuroimaging. 2016;26(2):161–8.

    PubMed  Google Scholar 

  12. Cosenza-Nashat M, Zhao ML, Suh HS, Morgan J, Natividad R, Morgello S, et al. Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol. 2009;35(3):306–28.

    CAS  PubMed  Google Scholar 

  13. Vowinckel E, Reutens D, Becher B, Verge G, Evans A, Owens T, et al. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res. 1997;50(2):345–53.

    CAS  PubMed  Google Scholar 

  14. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain. 2000;123(Pt 11):2321–37.

    PubMed  Google Scholar 

  15. Debruyne JC, Versijpt J, Van Laere KJ, De Vos F, Keppens J, Strijckmans K, et al. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195. Eur J Neurol. 2003;10(3):257–64.

    CAS  PubMed  Google Scholar 

  16. Politis M, Giannetti P, Su P, Turkheimer F, Keihaninejad S, Wu K, et al. Increased PK11195 PET binding in the cortex of patients with MS correlates with disability. Neurology. 2012;79(6):523–30.

    PubMed  PubMed Central  Google Scholar 

  17. Datta G, Colasanti A, Rabiner EA, Gunn RN, Malik O, Ciccarelli O, et al. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis. Brain. 2017;140(11):2927–38.

    PubMed  Google Scholar 

  18. Dula AN, Asche EM, Landman BA, Welch EB, Pawate S, Sriram S, et al. Development of chemical exchange saturation transfer at 7 T. Magn Reson Med. 2011;66(3):831–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Zu Z. Towards the complex dependence of MTRasym on T1w in amide proton transfer (APT) imaging. NMR Biomed. 2018;31(7):e3934.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiology, Department of Diagnostic and Public Health, Verona University, Verona, Italy

    Francesca Benedetta Pizzini

  2. Neuroradiology Unit, University Hospital of Padua, Padua, Italy

    Giacomo Talenti

Authors
  1. Francesca Benedetta Pizzini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giacomo Talenti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesca Benedetta Pizzini .

Editor information

Editors and Affiliations

  1. Division of Neuroradiology, Thomas Jefferson University, Philadelphia, PA, USA

    Scott H. Faro

  2. Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USA

    Feroze B. Mohamed

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pizzini, F.B., Talenti, G. (2023). Functional Neuroradiology of Multiple Sclerosis: Non-BOLD Techniques. In: Faro, S.H., Mohamed, F.B. (eds) Functional Neuroradiology. Springer, Cham. https://doi.org/10.1007/978-3-031-10909-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-10909-6_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-10908-9

  • Online ISBN: 978-3-031-10909-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation